Osteonecrosis clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
open to eligible people ages 18-80
A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
at UC Davis
Sickle Cell Disease (SCD) Bone Pain Study
Sorry, in progress, not accepting new patients
A prospective study to determine how low bone mineral density and/or vertebral compression fractures associate with pain in adults with sickle cell disease
at UC Davis
Our lead scientists for Osteonecrosis research studies include Oyebimpe O Adesina, MD, MS.
Last updated: